Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2094
Title: Tspan5 inhibits proliferation and migration of JEG-3 cells by inhibiting FAK and AKT phosphorylation
Authors: X. Ren, X. Ren
Keywords: Tspan5
Human choriocarcinoma cell line JEG-3
Proliferation
Migration
FAK/AKT
Issue Date: Apr-2019
Abstract: Tspan5 inhibits proliferation and migration of JEG-3 cells by inhibiting FAK and AKT phosphorylation X. Ren 1* , H-Y. Tang 2* , J.Wu 1 , T-Y. Gao 1* , J. Li 1 1Department of Reproductive Medicine, Guangdong No.2 Provincial People’s Hospital, Guangzhou 2Department of Reproductive Medicine, Meizhou People's Hospital, Meizhou, Guangdong (China) Summary Objectives: To study the effect of Tspan5 on the proliferation and migration of trophoblast cells. Materials and Methods: The authors silenced the Tspan5 expression in human choriocarcinoma cell line JEG-3 using RNAi, and then conducted the cell proliferation assay and scratch assay to detect the proliferation and migration of JEG-3 cells. Results: The present authors found that the JEG-3 cell proliferation and migration activity of interference group (Tspan5/1005) had decreased significantly. Tspan5/1005 moderately decreased FAK and AKT phosphorylation compared to the control group. In this study, the authors found that the proliferation and migration of choriocarcinoma cells were reduced after using RNAi technology to downregulate the expression level of Tspan5 expression. The level of Tspan5 expression was positively correlated with the proliferation and migration of choriocarcinoma cells. Conclusions: Tspan5 could play a biological role through the FAK/AKT signaling pathway. Key words: Tspan5; Human choriocarcinoma cell line JEG-3; Proliferation; Migration; FAK/AKT.
URI: http://localhost:8080/xmlui/handle/123456789/2094
Appears in Collections:2. Clinical and Experimental Obstetrics & Gynecology

Files in This Item:
File Description SizeFormat 
0390-6663-46-2-280.pdf532.97 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.